A. Schema of NSABP B-27 trial comparing neoadjuvant AC to neoadjuvant AC followed by neoadjuvant docetaxel and to neoadjuvant AC followed by adjuvant docetaxel in patients with operable breast cancer. B. Comparison of disease-free survival by treatment and pCR. (Tam, tamoxifen.) Source: Chapter 42. The NSABP Experience, Kuerer's Breast Surgical Oncology Citation: Kuerer HM. Kuerer's Breast Surgical Oncology; 2010 Available at: http://accesssurgery.mhmedical.com/DownloadImage.aspx?image=/data/books/kuer/kuer_c042f025b.gif&sec=39939853&BookID=428&ChapterSecID=39936171&imagename= Accessed: October 13, 2017 Copyright © 2017 McGraw-Hill Education. All rights reserved